A lot of good things have happened at ConocoPhillips (NYSE: COP), but none of them matter much because of one overriding issue. At the end of May 2024, ConocoPhillips announced that it was planning to ...
In this perspective, the authors describe a directed evolution mode of nanomedicines driven by data to accelerate the discovery of nanomaterials with high delivery efficiency. Individualized ...
Nvidia has rocketed to all-time highs, but investors should hold on a while longer as the company's next-generation Blackwell GPU will be a watershed moment, a note from Melius Research this week ...
Clinical trial setbacks could significantly impact Perspective Therapeutics' valuation. As a clinical-stage biotech company, much of CATX's value is tied to the potential of its pipeline. Any negative ...
The Trump victory-fueled, post-election market rally has investors cheering for now. However, outspoken economist Harry Dent is still bearish about America’s private debt and the future of its ...